Baba Ramdev and Acharya Balakrishna would not have been so brazen had it not been for the tacit support of the state machinery. Having opened a can of worms, the Supreme Court now has also rightly expanded the scope of the case to other unethical FMCG advertising.
The Patanjali case is a frightening example of how money is to be made by peddling hocus pocus as remedies, and then using people's fears against modern medicine to promote products that have doubtful efficacy.
As far back as 2019, the company splashed advertising for eyedrops which it claimed was "helpful in treating glaucoma or cataract, double vision, color vision, retinitis pigmentosa and night blindness". Though in violation of the Drugs and Magic Remedies (Objectional Advertisements) Act (DMRA) 1954, no action was taken.
Between February and October 2022, the Uttarakhand State Licensing Authority (SLA) and Drug Controller of Indian were alerted to several Patanjali campaigns for drugs that claimed to cure diabetes, and bring down cholesterol levels. Most dangerous was the one forits drug 'Coronil' launched in February 2021 that claimed to arrest the covid-19 virus. How can any regulator take action, if the then Union Health Minister Harsh Vardhan flagged off the launch!
The court battle
The second leg of Baba Ramdev's ad campaign was against allopathic medicines. In a video that went viral, he said modern medicines hadkilled off lakhs of patients. Finally, the Indian Medical Association (IMA)filed a petition challenging Baba Ramdev and notice was issued in August 2022 by the Supreme Court.
هذه القصة مأخوذة من طبعة April 28, 2024 من The New Indian Express.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة April 28, 2024 من The New Indian Express.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
An effective Arjun Das anchors this middling film
SANTHAKUMAR’S latest film, Rasavathi, takes its name from the term alchemist, denoting some one who seeks to transmute base metal into gold, formulate the elixir of immortality, or create a cure-all medicine.
Some momentary joys in this not-so-deep take on pursuit of passion
I thought of Vaaranam Aayiram many times while watching Star. It’s not just because of Kavin’s early looks, as Kalai, or his dance moves. There’s more.
Titanic display in Ahmedabad
Openers Gill and Sudharsan crack tons, help Gujarat prevail in must-win game vs Chennai SWAROOP SWAMINATHAN @ Chennai ONE of the primary themes of the current Indian Premier League (IPL) season has been MS Dhoni's farewell tour (at least that's the buzz).
Neeraj begins season with second-place finish behind Vadlejch
A COUPLE of days ahead of the Doha Diamond League, Neeraj Chopra's coach, Klaus Bartonietz, had said that first event of the season would always be tricky.
Harmanpreet & Co gain valuable insights
WHEN India's five T20I match tour of Bangladesh was announced, the bugle for preparing for the upcoming T20 World Cup was officially blown.
Woman wrestler Nisha qualifies for Olympics
NISHA Dahiya on Friday became the fifth Indian woman wrestler to earn a quota for the 2024 Paris Olympics.
Athletes specific support staff for Paris: Usha
THE Indian Olympic Association on Friday announced that athletes will get sports specific support staff during the Paris Olympics from July 26 to August 11.
TVS Holdings to buy 80.74% stake in Home Credit India for ₹554 cr
CHENNAI-based TVS Holdings is acquiring 80.74% of the equity stake in Home Credit India Finance (HCIFPL) for 554 crore.
BPCL crude imports from Russia to fall in FY25, to buy 25% of total requirement
STATE-owned Bharat Petroleum Corporation Limited (BPCL) said, in its investors call, it will import 25% of its total crude oil needs from Russia in FY 2024-25.
Goair, pension provisions drag down BoB earnings
AN additional ₹550 crore provision for bankrupt Goair, along with another ₹800 crore for pensions, has scuppered the overall numbers of Bank of Baroda, which on Friday reported a muted 2.3% growth in net income at 4,886 crore for the March quarter.